Skip to main content
Back to Qiming Venture Partners

Qiming Venture Partners's Life Science Portfolio

Browse 19 Life Science companies funded by Qiming Venture Partners. See funding amounts, founder contacts, and investment details.

Life Science Companies
19
Total Funding in Life Science
$1.3B

Life Science Portfolio Companies (19)

Export
BiotechnologyLife ScienceTherapeutics

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Berkeley, United States
July 2025
$54.5M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceOncologyPharmaceuticalPrecision Medicine

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

New York, United States
June 2023
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedical

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

Watertown, United States
June 2026
$10.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Amsterdam, The Netherlands
June 2026
$45.4M
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

Basel, Switzerland
May 2026
$165.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Boston, United States
March 2024
$47.1M
Series F

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Seattle, United States
August 2024
$144.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsLife ScienceOncology

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Vancouver, Canada
April 2023
$142.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyEdiscoveryLife ScienceProduct Research

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

Watertown, United States
November 2021
$75.5M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Powering precision proteomics to enable to the earliest detection of disease.

Fremont, United States
January 2026
$50.0M
Convertible Note

Founder Contacts

30,000+ verified contacts

Health CareHealth DiagnosticsLife ScienceTherapeutics

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

South San Francisco, United States
October 2022
$12.2M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

ChemLex is a chemical synthesis CRO that was founded by Magera Technology.

Shanghai, China
December 2025
$45.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife Science

Chenzhang Bio is a biotechnology developer specializing in stem cell storage and treatment technology.

Chongqing, China
August 2024
$2.8M
Seed

Founder Contacts

30,000+ verified contacts

Big DataDatabaseHealth CareLife ScienceSoftware

Prime Lifescience is a developer of a big data platform that focuses on life sciences.

Hangzhou, China
December 2023
$14.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Abogen Biosciences is a clinical stage biotechnology company focuses on developing nucleic acid-based RNA therapeutics.

Suzhou, China
November 2021
$300.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsLife ScienceTherapeutics

Basecamp Bio develops cell and gene therapies, regenerative medicine, and immunotherapies.

Waltham, United States
March 2021
$14.0M
Angel

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceutical

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

Shanghai, China
July 2020
$97.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.

Beijing, China
March 2020
$10.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyDelivery ServiceHealth CareLife Science

BBI Life Sciences Corporation providers the life sciences research products and services industry.

Shanghai, China
March 2015
$10.3M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

Explore Qiming Venture Partners's Full Portfolio

View all companies funded by Qiming Venture Partners across every industry and funding stage.

View Full Qiming Venture Partners Portfolio